524 results
8-K
EX-3.1
CTIC
CTI BioPharma Corp
26 Jun 23
Termination of a Material Definitive Agreement
8:51am
.
THIRD: The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may
SC 14D9
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or payable to any of the officers
SC 14D9
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
of the Offer have been satisfied or waived (if permitted thereunder, and other than any such conditions of the Offer that by their nature are to be satisfied … nature becomes less reliable with each successive year.
In light of the foregoing factors and the uncertainties inherent in the Management Projections
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
(if permitted thereunder, and other than any such conditions of the Offer that by their nature are to be satisfied at the expiration of the Offer
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
that by their nature are to be satisfied at the expiration of the Offer (provided such conditions would be capable of being satisfied or validly waived were … satisfied or waived (if permitted thereunder, and other than any such conditions of the Offer that by their nature are to be satisfied at the expiration
SC TO-T
EX-99
un7oxsyzjh e67q40ci
25 May 23
Third party tender offer statement
6:46am
SC TO-C
EX-99.1
g3tgumkp6vbo7g
10 May 23
Information about tender offer
5:01pm
SC14D9C
EX-99.1
cq9yie
10 May 23
Written communication relating to third party tender offer
1:30pm
SC14D9C
EX-2.1
sbyz065ibpeneuu
10 May 23
Written communication relating to third party tender offer
1:30pm
SC14D9C
blv0yet
10 May 23
Written communication relating to third party tender offer
1:30pm
SC14D9C
EX-3.1
85ykc
10 May 23
Written communication relating to third party tender offer
1:30pm
8-K
EX-99.1
6v97mfighx0j 42xtu
10 May 23
Tender and Support Agreement
8:05am
8-K
wf4l8
10 May 23
Tender and Support Agreement
8:05am
8-K
EX-3.1
zy5urmfxg79vsup zh
10 May 23
Tender and Support Agreement
8:05am
8-K
EX-2.1
ndu8oa9epv
10 May 23
Tender and Support Agreement
8:05am
8-K
EX-99.1
es7 634uz
7 Nov 22
CTI BioPharma Reports Third Quarter 2022 Financial Results
4:07pm